Search results
Results from the Go Local Guru Content Network
NextGen Healthcare, Inc. is an American software and services company headquartered in Atlanta, Georgia. The company develops and sells electronic health record (EHR) software and practice management systems to the healthcare industry.
Patient portals are healthcare-related online applications that allow patients to interact and communicate with their healthcare providers, such as physicians and hospitals. Typically, portal services are available on the Internet at all hours of the day and night.
The messages have to do with medical treatment assistance including the delivery and refill reminders of medication and patient monitoring for people with chronic diseases. It was founded in 2003 in Birmingham, Alabama. Medfusion manages $270 million in drug spending.
The U.S. Food and Drug Administration issued a Class I recall, the agency's most serious, for the Medfusion syringe pump, the third major FDA recall for the line of devices made in Oakdale.
May 13, 2024 at 4:22 PM. Pfizer Follows Eli Lilly's Footsteps To Sell Medicines Directly To Patients. Pfizer Inc (NYSE: PFE) is looking to build on the success of its COVID-19 vaccine rollout by ...
St. Mary’s Health Care System has launched a new patient portal, MyHealth, that gives anyone who receives care at St. Mary’s the power to access their electronic medical record 24 hours a day...
USMD Expands its Organization to Support Growing Needs of Communities and Patients New Physicians Treat Patients from Babies to Baby Boomers, Many Accept Medicare IRVING, Texas--(BUSINESS WIRE ...
Since then, the product has evolved into a suite of "patient engagement services," including a patient portal, patient self-scheduling solution, and live operator service to better help patients to schedule appointments, reschedule appointments, and make payments.
Online patient education, also known as online patient engagement, is a method of providing medical information and education to patients using learning management systems delivered through the Internet.
May 6, 2024 at 7:46 AM. (Reuters) -Gossamer Bio said on Monday it will collaborate with Italian drugmaker Chiesi Group to develop and commercialize its therapy seralutinib in multiple indications ...